Last reviewed · How we verify
Vitamin D2
At a glance
| Generic name | Vitamin D2 |
|---|---|
| Also known as | Vit D2, 21st Century Dietary Supplement, Ergocalciferol, cholecalciferol, Ergocalciferol Placebo |
| Sponsor | Wenhu Liu |
| Drug class | Provitamin D2 Compound [EPC] |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
- Nausea
- Anorexia
- Constipation
- Polyuria
- Polydipsia
- Nocturia
- Vague aches
- Stiffness
- Weakness
- Weight loss
- Anemia
- Mild acidosis
Serious adverse events
- Renal insufficiency
- Nephrocalcinosis
- Hypercalciuria
- Reversible azotemia
- Impairment of renal function
- Generalized vascular calcification
- Widespread calcification of soft tissues
- Mental retardation
- Bone demineralization (osteoporosis)
- Dwarfism
Key clinical trials
- Frequency of Fibromyalgia Syndrome in Elderly Patients Aged 80 and Above and Its Relationship With Geriatric Parameters
- Immune Mechanisms of Vitamin D to Reduce Chronic Pain After Burn (PHASE2)
- Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease (PHASE2)
- High-Dose vs Standard Ergocalciferol for Vitamin D Normalization in Aggressive Non-Hodgkin Lymphoma (NA)
- Chemo Brain Prehab Project (NA)
- Vitamin D Homeostasis in Sarcoidosis (PHASE4)
- Vitamin D Deficiency in Adults Following a Major Burn Injury (PHASE4)
- Vitamin D in OUD: Exploration of Alterations on the Dopamine D2/D3 Receptor System (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |